This arrangement, the lawsuit claims, effectively lowered Eylea's selling price and provided Regeneron with a competitive advantage in the anti-VEGF medication market. The Department of Justice ...

Regeneron Pharmaceuticals has built its success on a foundation of innovative drug development, with key products including Eylea for eye diseases and Dupixent for various inflammatory conditions.

The treatment is a biosimilar that could compete with Regeneron Pharmaceuticals’ Eylea. Teva and Alvotech have been working together in a strategic partnership since 2020. Teva Pharmaceutical ...

The trial, designed to compare the efficacy, safety, and immunogenicity of AVT06 with Eylea, reached the main goal, according to its topline data from January 2024. The duo said the FDA process to ...

"We are extremely pleased with this new step in the development of our biosimilar candidate to Eylea ®, as better access will benefit patients and their caregivers," said Joseph McClellan ...

Regeneron and Bayer's efforts to defend their lucrative eye disease therapy Eylea from competition have been boosted by FDA approval of a new high-dose formulation of the drug. The US regulator ...

THURSDAY 20 FEBRUARY, 2025 - INCHEON, SOUTH KOREA – Celltrion today announced that the European Commission (EC) has granted marketing authorization for three products across two biosimilars: Eydenzelt ...

FYB203 (aflibercept) approved in the UK for the treatment of neovascular age-related macular degeneration (nAMD) and several other severe retinal diseases UK market authorization follows successful ...

Novartis is launching a head-to-head trial of its experimental brolucizumab therapy for age-related macular degeneration (AMD) against Bayer/Regeneron’s Eylea, the market leader. The TALON trial ...

Life moves at a different pace for everyone, but that doesn't mean it's easy to keep yourself from comparing the progress of your life to that of someone else. While some people reach their peak ...

The Nexon EV reigns triumphant over the Windsor in our rolling acceleration test. From 20-80kph, the Tata EV outperformed the Windsor by 0.2 seconds. In the 40-100kph dash, the gap widened further ...

MG Windsor price range is Rs 13.50 lakh and Rs 15.50 lakh (ex-showroom) Battery-as-a-Service (BAAS) option reduces initial cost by Rs 3.5 lakh Battery warranty & car warranty: 8 years/1.6 lakh km ...